Arkolith/Insider Trading/ARCT/Form 4/A

Sassine Andy

Chief Financial Officer, DirectorArcturus Therapeutics Holdings Inc. (ARCT) · full profile →Form 4/A · filed Aug 20, 2025
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 15, 2025Buy(P)1K$16.56$21K222K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001193805-25-001215) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML